In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries

Catheterization and Cardiovascular Interventions

Volumn 80, Issue 3, 2012, Pages 429-436

  Waksman, Ron ^a   Pakala, Rajbabu ^a   Baffour, Richard ^a   Seabron, Rufus ^a   Hellinga, David ^a   Chan, Rosanna ^a   Su, Shih Horng ^b   Kolodgie, Frank ^c   Virmani, Renu ^c  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b Biosensors International   (Singapore)

^c CVPATH INSTITUTE   (United States)

Author keywords

biolimus A9; drug eluting stent; neointima; polymer

Indexed keywords

FIBRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BARE METAL STENT; CHOLESTEROL DIET; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ELUTING STENT; GIANT CELL; HYPERCHOLESTEROLEMIA; ILIAC ARTERY; IN VIVO STUDY; IN-STENT RESTENOSIS; INFLAMMATION; MALE; MORPHOMETRICS; NONHUMAN; RABBIT;

ABSORBABLE IMPLANTS; ANGIOPLASTY, BALLOON; ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR AGENTS; CONSTRICTION, PATHOLOGIC; DISEASE MODELS, ANIMAL; DRUG-ELUTING STENTS; FIBRIN; HYPERCHOLESTEROLEMIA; HYPERPLASIA; ILIAC ARTERY; INFLAMMATION; MALE; METALS; NEOINTIMA; PLAQUE, ATHEROSCLEROTIC; POLYMERS; PROSTHESIS DESIGN; RABBITS; SIROLIMUS; STENTS; TIME FACTORS;

EID: 84865652739     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23407     Document Type: Article

References (33)

1. Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB,. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998; 31: 224-230. (Pubitemid 28064746)
2. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW,. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007; 356: 989-997. (Pubitemid 46376799)
3. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabaté M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schömig A,. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007; 356: 1030-1039. (Pubitemid 46376803)
4. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB,. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007; 356: 998-1008. (Pubitemid 46376800)
5. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE,. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007; 356: 1020-1029. (Pubitemid 46376802)
6. Lüscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, Virmani R,. Drug-eluting stent and coronary thrombosis: Biological mechanisms and clinical implications. Circulation 2007; 115: 1051-1058 (Pubitemid 46328299)
7. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R,. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202. (Pubitemid 43929240)
8. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R,. Vascular responses to drug eluting stents: Importance of delayed healing. Arterioscler Thromb Vasc Biol 2007; 27: 1500-1510. (Pubitemid 46986103)
9. Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, Gold HK, Burke AP, Kolodgie FD, Virmani R,. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: An autopsy study. Circulation 2008; 118: 1138-1145.
10. John MC, Wessely R, Kastrati A, Schömig A, Joner M, Uchihashi M, Crimins J, Lajoie S, Kolodgie FD, Gold HK, Virmani R, Finn AV,. Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents. JACC Cardiovasc Interv 2008; 1: 535-544.
11. Byrne RA, Joner M, Kastrati A,. Polymer coatings and delayed arterial healing following drug-eluting stent implantation. Minerva Cardioangiol 2009; 57: 567-584.
12. Mehilli J, Byrne RA, Wieczorek A, Iijima R, Schulz S, Bruskina O, Pache J, Wessely R, Schomig A, Kastrati A,. Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis. Eur Heart J 2008; 29: 1975-1982.
13. Windecker S, Serruys PW, Wandel S, Buszman P, Trznadel S, Linke A, Lenk K, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice MC, di Mario C, Davies S, van Geuns RJ, Eerdmans P, van Es GA, Meier B, Juni P,. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): A randomised non-inferiority trial. Lancet 2008; 372: 1163-1173.
14. Steigerwald K, Merl S, Kastrati A, Wieczorek A, Vorpahl M, Mannhold R, Vogeser M, Hausleiter J, Joner M, Schomig A, Wessely R,. The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts. Biomaterials 2009; 30: 632-637.
15. Mehilli J, Kastrati A, Wessely R, Dibra A, Hausleiter J, Jaschke B, Dirschinger J, Schoimig A,. Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss. Circulation 2006; 113: 273-279.
16. Byrne RA, Mehilli J, Iijima R, Schulz S, Pache J, Seyfarth M, Schomig A, Kastrati A,. A polymer-free dual drug-eluting stent in patients with coronary artery disease: A randomized trial vs. polymer-based drug-eluting stents. Eur Heart J 2009; 30: 923-931.
17. Pakala R, Leborgne L, Cheneau E, Chan RC, Yazdi H, Fournadjiev J, Weber D, Hellinga D, Kolodgie, F, Virmani R, Waksman R,. Radiation-induced atherosclerotic plaque progression in a hypercholesterolemic rabbit: A prospective vulnerable plaque model? Cardiovasc Radiat Med 2003; 4: 146-151. (Pubitemid 38230307)
18. Leborgne L, Pakala R, Dilcher C, Hellinga D, Seabron R, Tio FO, Waksman R,. Effect of antioxidants on atherosclerotic plaque formation in balloondenuded and irradiated hypercholesterolemic rabbits. J Cardiovasc Pharmacol 2005; 46: 540-547. (Pubitemid 41407585)
19. Pakala R, Dilcher C, Baffour R, Hellinga D, Seabron R, Joner M, Kolodgie, F, Virmani R, Waksman R,. Peroxisome proliferator-activated receptor gamma ligand pioglitazone alters neointimal composition in a balloon-denuded and radiated hypercholesterolemic rabbit. J Cardiovasc Pharmacol 2006; 48: 299-305. (Pubitemid 46066835)
20. Waksman R, Pakala R, Roy P, Baffour R, Hellinga D, Seabron R, Chan R, Scheinowitz M, Kolodgie, F, Virmani R,. Effect of clopidogrel on neointimal formation and inflammation in balloon-denuded and radiated ypercholesterolemic rabbit iliac arteries. J Interv Cardiol 2008; 21: 1221-1228.
21. Sousa JE, Costa MA, Abizaid AC, Rensing BJ, Abizaid AS, Tanajura LF, Kozuma K, Van Langenhove G, Sousa AG, Falotico R, Jaeger J, Popma JJ, Serruys PW,. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: One-year angiographic and intravascular ultrasound follow-up. Circulation 2001; 104: 2007-2011. (Pubitemid 33027038)
22. Liistro F, Stankovic G, Di Mario C, Takagi T, Chieffo A, Moshiri S, Montorfano M, Carlino M, Briguori C, Pagnotta P, Albiero R, Corvaja N, Colombo A,. First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: Immediate and long-term clinical and angiographic outcome. Circulation 2002; 105: 1883-1886. (Pubitemid 34437612)
23. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW,. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-1521. (Pubitemid 39410418)
24. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, Jeger R, Bader F, Osswald S, Kaiser C,; BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006; 48: 2584-2591. (Pubitemid 44881238)
25. Wessely R, Kastrati A, Schoimig A,. Late restenosis in patients receiving a polymercoated sirolimus-eluting stent. Ann Intern Med 2005; 143: 392-394. (Pubitemid 41266615)
26. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD,. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious? Circulation 2004; 109: 701-705. (Pubitemid 38222887)
27. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, Davidson CJ, McKoy JM, Raisch DW, Whisenant BK, Yarnold PR, Belknap SM, West DP, Gage JE, Morse RE, Gligoric G, Davidson L, Feldman MD,. Hypersensitivity cases associated with drug-eluting coronary stents: A review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006; 47: 175-181. (Pubitemid 43005183)
28. Grube E, Buellesfeld L,. BioMatrix Biolimus A9-eluting coronary stent: A next-generation drug-eluting stent for coronary artery disease. Expert Rev Med Devices 2006; 3: 731-741. (Pubitemid 46017613)
29. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R,. Vascular responses to drug eluting stents: Importance of delayed healing. Arterioscler Thromb Vasc Biol 2007; 27: 1500-1510. (Pubitemid 46986103)
30. Suzuki T, Kopia G, Hayashi S, Bailey LR, Llanos G, Wilensky R, Klugherz BD, Papandreou G, Narayan P, Leon MB, Yeung AC, Tio F, Tsao PS, Falotico R, Carter AJ,. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001; 104: 1188-1193. (Pubitemid 32830406)
31. Parry TJ, Brosius R, Thyagarajan R, Carter D, Argentieri D, Falotico R, Siekierka J,. Drug-eluting stents: Sirolimus and paclitaxel differentially affect cultured cells and injured arteries. Eur J Pharmacol 2005; 524: 19-29. (Pubitemid 41606808)
32. Axel DI, Kunert W, Goggelmann C, Oberhoff M, Herdeg C, Kuttner A, Wild DH, Brehm BR, Riessen R, Koveker G, Karsch KR,. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997; 96: 636-645. (Pubitemid 27329445)
33. Vinals F, Chambard JC, Pouyssegur J,. p70 S6 kinase-mediated protein synthesis is a critical step for vascular endothelial cell proliferation. J Biol Chem 1999; 274: 26776-26782.